Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers

2017/04/03 by Vivian K.Y. Leung, Vivian Leung, Louise A. Carolan +10 · 25 citations
Medicine · #Influenza Virus Research Studies #Infection Control and Ventilation #Respiratory viral infections research

paper · doi:10.1016/j.vaccine.2017.03.063

Cited by

• Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016
• Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection. [europepmc]
• Paediatric Virology and its interaction between basic science and clinical practice (Review). [europepmc]
• Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets. [europepmc]
• Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season. [europepmc]
• Comparison of immunogenicity between intradermal and intramuscular injections of repeated annual identical influenza virus strains post-pandemic (2011-2012) in COPD patients. [europepmc]
• Stability of Inactivated Influenza Vaccine in Polypropylene Syringes under Various Storage Conditions. [europepmc]
• Challenges of Making Effective Influenza Vaccines. [europepmc]
• Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. [europepmc]
• Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers. [europepmc]
• MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells. [europepmc]
• Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread. [europepmc]
• Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes. [europepmc]
• Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). [europepmc]
• Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses. [europepmc]
• Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 months. [europepmc]
• Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor. [europepmc]
• Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination. [europepmc]
• Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. [europepmc]
• Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants. [europepmc]
• Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel. [europepmc]
• Immune Response Against Influenza in a Cohort of Repeatedly Vaccinated Adults During the 2017/2018 and 2018/2019 Seasons. [europepmc]
• Comparison of the immunogenicity of adjuvanted and conventional egg-based quadrivalent influenza vaccines among healthcare personnel in Lima, Peru: A randomized controlled trial. [europepmc]
• Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammation. [europepmc]
• Low effectiveness of influenza vaccines vis-à-vis mechanism of protection by vaccines - potential causes and recommendations to improve control of influenza. [europepmc]